title: Determinants of left ventricular thrombus formation after primary percutaneous coronary intervention for anterior wall myocardial infarction.
abstract: Previous studies have reported that left ventricular (LV) thrombus is a complication in 10-56% of ST-segment elevation acute anterior wall myocardial infarctions (AWMI). Data suggest that changes in acute myocardial infarction management such as early anticoagulation, thrombolysis, and most recently, primary percutaneous coronary intervention (PCI), may decrease thrombus occurrence. Early time to reperfusion has been shown to decrease mortality and improve LV function recovery. To determine if door-to-balloon time (DTBT) affects the incidence of LV thrombus, we retrospectively analyzed data on 43 consecutive patients who underwent successful PCI of a primary acute ST-segment elevation AWMI. Transthoracic echocardiography was performed for detecting LV thrombus and measuring LV ejection fraction (EF) within 5 days on all patients (average time: 2.17 days post event). Nineteen patients underwent PCI within 2 h of arrival to the Emergency Department (Group A, average 88 min) and 24 patients underwent PCI with DTBT of more than 2 h (Group B, average 193 min). Clinically significant LV thrombus was detected in 35% of all patients. The incidence of LV thrombus formation in Group A was not significantly different from that in Group B (42.1% vs. 29.0%, respectively; P = 0.52). The risk of LV thrombus was independent of in-hospital anticoagulation and medical management, peak enzyme levels, and LVEF but did relate to age (odds ratio = 1.96, 95% CI 1.03-3.73, P = 0.04 per decade). No embolic events in hospital were observed (average hospital stay 9.2 days). We conclude that the incidence of LV thrombus remains high despite PCI. Also, we find that DTBT in patients presenting with an ST-segment elevation AWMI does not affect the incidence of LV thrombus formation. Increased age, however, does appear to increase the risk of LV thrombus development.
authors.affiliation: Division of Cardiology, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA. ler8@columbia.edu
authors.forename: LeRoy Elazar
authors.initials: LE
authors.lastname: Rabbani
authors.forename: Carol
authors.initials: C
authors.lastname: Waksmonski
authors.forename: Sohah N
authors.initials: SN
authors.lastname: Iqbal
authors.forename: Jennifer
authors.initials: J
authors.lastname: Stant
authors.forename: Robert
authors.initials: R
authors.lastname: Sciacca
authors.forename: Mark
authors.initials: M
authors.lastname: Apfelbaum
authors.forename: Osman R
authors.initials: OR
authors.lastname: Sayan
authors.forename: James
authors.initials: J
authors.lastname: Giglio
authors.forename: Shunichi
authors.initials: S
authors.lastname: Homma
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications* / Q000628:therapy; D015425:Myocardial Reperfusion; D012189:Retrospective Studies; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors